1. Elham A, Arken M, Kalimanjan G, Arkin A, Iminjan M. A review of the phytochemical, pharmacological, pharmacokinetic, and toxicological evaluation of Quercus Infectoria galls. J Ethnopharmacol. 2021;273:113592. [
DOI:10.1016/j.jep.2020.113592] [
PMID]
2. Kaur G, Athar M, Alam MS. Quercus infectoria galls possess antioxidant activity and abrogates oxidative stress-induced functional alterations in murine macrophages. Chem Biol Interact. 2008;171(3):272-82. [
DOI:10.1016/j.cbi.2007.10.002] [
PMID]
3. Vermani A; Navneet; Prabhat. Screening of Quercus infectoria gall extracts as anti-bacterial agents against dental pathogens. Indian J Dent Res. 2009;20(3):337-9. [
DOI:10.4103/0970-9290.57380] [
PMID]
4. Nair M, Sandhu SS, Sharma AK. Cancer molecular markers: A guide to cancer detection and management. Semin Cancer Biol. 2018;52(Pt 1):39-55. [
DOI:10.1016/j.semcancer.2018.02.002] [
PMID]
5. Meacham CE, Morrison SJ. Tumour heterogeneity and cancer cell plasticity. Nature. 2013;501(7467):328-37. [
DOI:10.1038/nature12624] [
PMID] [
]
6. Fisher R, Pusztai L, Swanton C. Cancer heterogeneity: implications for targeted therapeutics. Br J Cancer. 2013;108(3):479-85. [
DOI:10.1038/bjc.2012.581] [
PMID] [
]
7. Dunn BK, Wagner PD, Anderson D, Greenwald P. Molecular markers for early detection. Semin Oncol. 2010;37(3):224-42. [
DOI:10.1053/j.seminoncol.2010.05.007] [
PMID]
8. Heist RS, Sequist LV, Engelman JA. Genetic changes in squamous cell lung cancer: a review. J Thorac Oncol. 2012;7(5):924-33. [
DOI:10.1097/JTO.0b013e31824cc334] [
PMID] [
]
9. Shivapurkar N, Reddy J, Chaudhary PM, Gazdar AF. Apoptosis and lung cancer: a review. J Cell Biochem. 2003;88(5):885-98. [
DOI:10.1002/jcb.10440] [
PMID]
10. Liu G, Pei F, Yang F, Li L, Amin AD, Liu S, et al. Role of Autophagy and Apoptosis in Non-Small-Cell Lung Cancer. Int J Mol Sci. 2017;18(2):367. [
DOI:10.3390/ijms18020367] [
PMID] [
]
11. Sekido Y, Fong KM, Minna JD. Molecular genetics of lung cancer. Annu Rev Med. 2003;54:73-87. [
DOI:10.1146/annurev.med.54.101601.152202] [
PMID]
12. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69-90. [
DOI:10.3322/caac.20107] [
PMID]
13. Lv L, Liang X, Wu D, Wang F, Zhang Y, Cang H, et al. Is cardia cancer a special type of gastric cancer? A differential analysis of early cardia cancer and non-cardia cancer. J Cancer. 2021;12(8):2385-2394. [
DOI:10.7150/jca.51433] [
PMID] [
]
14. Ilic M, Ilic I. Epidemiology of stomach cancer. World J Gastroenterol. 2022;28(12):1187-1203. [
DOI:10.3748/wjg.v28.i12.1187] [
PMID] [
]
15. Haghighat P, Bekaii-Saab T. An update on biochemotherapy of advanced gastric and gastroesophageal adenocarcinoma. J Natl Compr Canc Netw. 2008;6(9):895-900. [
DOI:10.6004/jnccn.2008.0068] [
PMID]
16. Dang Y, Liu T, Yan J, Reinhardt JD, Yin C, Ye F, Zhang G. Gastric cancer proliferation and invasion is reduced by macrocalyxin C via activation of the miR-212-3p/Sox6 Pathway. Cell Signal. 2020;66:109430. [
DOI:10.1016/j.cellsig.2019.109430] [
PMID]
17. Yang CS, Chen X, Tu S. Etiology and Prevention of Esophageal Cancer. Gastrointest Tumors. 2016;3(1):3-16. [
DOI:10.1159/000443155] [
PMID] [
]
18. Kuwano H, Kato H, Miyazaki T, Fukuchi M, Masuda N, Nakajima M, et al. Genetic alterations in esophageal cancer. Surg Today. 2005;35(1):7-18. [
DOI:10.1007/s00595-004-2885-3] [
PMID]
19. Lao-Sirieix P, Caldas C, Fitzgerald RC. Genetic predisposition to gastro-oesophageal cancer. Curr Opin Genet Dev. 2010;20(3):210-7. [
DOI:10.1016/j.gde.2010.03.002] [
PMID]
20. Melhado RE, Alderson D, Tucker O. The changing face of esophageal cancer. Cancers (Basel). 2010;2(3):1379-404. [
DOI:10.3390/cancers2031379] [
PMID] [
]
21. Islami F, Kamangar F, Aghcheli K, Fahimi S, Semnani S, et al. Epidemiologic features of upper gastrointestinal tract cancers in Northeastern Iran. Br J Cancer. 2004;90(7):1402-6. [
DOI:10.1038/sj.bjc.6601737] [
PMID] [
]
22. Huang FL, Yu SJ. Esophageal cancer: Risk factors, genetic association, and treatment. Asian J Surg. 2018;41(3):210-215. [
DOI:10.1016/j.asjsur.2016.10.005] [
PMID]
23. Holm K, Staaf J, Jönsson G, Vallon-Christersson J, Gunnarsson H, Arason A, et al. Characterisation of amplification patterns and target genes at chromosome 11q13 in CCND1-amplified sporadic and familial breast tumours. Breast Cancer Res Treat. 2012;133(2):583-94. [
DOI:10.1007/s10549-011-1817-3] [
PMID]
24. Pestell RG. New roles of cyclin D1. Am J Pathol. 2013;183(1):3-9. [
DOI:10.1016/j.ajpath.2013.03.001] [
PMID] [
]
25. Ara N, Atique M, Ahmed S, Ali Bukhari SG. Frequency of p53 gene mutation and protein expression in oral squamous cell carcinoma. J Coll Physicians Surg Pak. 2014;24(10):749-53.
26. Fiebig AA, Zhu W, Hollerbach C, Leber B, Andrews DW. Bcl-XL is qualitatively different from and ten times more effective than Bcl-2 when expressed in a breast cancer cell line. BMC Cancer. 2006;6:213. [
DOI:10.1186/1471-2407-6-213] [
PMID] [
]
27. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 1993;74(4):609-19. [
DOI:10.1016/0092-8674(93)90509-O] [
PMID]
28. Ziegler U, Groscurth P. Morphological features of cell death. News Physiol Sci. 2004;19:124-8. [
DOI:10.1152/nips.01519.2004] [
PMID]
29. Pistritto G, Trisciuoglio D, Ceci C, Garufi A, D'Orazi G. Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies. Aging (Albany NY). 2016;8(4):603-19. [
DOI:10.18632/aging.100934] [
PMID] [
]
30. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26(4):239-57. [
DOI:10.1038/bjc.1972.33] [
PMID] [
]
31. Ngabire D, Seong YA, Patil MP, Niyonizigiye I, Seo YB, Kim GD. Induction of apoptosis and G1 phase cell cycle arrest by Aster incisus in AGS gastric adenocarcinoma cells. Int J Oncol. 2018;53(5):2300-2308. [
DOI:10.3892/ijo.2018.4547] [
PMID]
32. Sayed Mahdi N, Azarbani F, Pirnia A, Abbaszadeh A, Gholami M. The Effect of Caffeic Acid on Spermatogonial Stem Cell-type A Cryopreservation. Rep Biochem Mol Biol. 2018;7(1):85-93.
33. Mohammadi A, Balizadeh Karami AR, Dehghan Mashtani V, Sahraei T, Bandani Tarashoki Z, Khattavian E, et al. Evaluation of Oxidative Stress, Apoptosis, and Expression of MicroRNA-208a and MicroRNA-1 in Cardiovascular Patients. Rep Biochem Mol Biol. 2021;10(2):183-196. [
DOI:10.52547/rbmb.10.2.183] [
PMID] [
]
34. Yusof WNSW, Abdullah H. Phytochemicals and Cytotoxicity of Quercus infectoria Ethyl Acetate Extracts on Human Cancer Cells. Trop Life Sci Res. 2020;31(1):69-84. [
DOI:10.21315/tlsr2020.31.1.5] [
PMID] [
]
35. Ludwig LM, Maxcy KL, LaBelle JL. Flow Cytometry-Based Detection and Analysis of BCL-2 Family Proteins and Mitochondrial Outer Membrane Permeabilization (MOMP). Methods Mol Biol. 2019;1877:77-91. [
DOI:10.1007/978-1-4939-8861-7_5] [
PMID] [
]
36. Abdullah H, Ismail I, Suppian R. Induction of apoptosis in HeLa cervical cancer cells treated with aqueous and supercritical fluid extracts of Quercus infectoria. Res J Pharmacogn. 2021;8(4):63-77.
37. Wyllie AH. Apoptosis: an overview. Br Med Bull. 1997;53(3):451-65. [
DOI:10.1093/oxfordjournals.bmb.a011623] [
PMID]
38. Shen Y, Luo Q, Xu H, Gong F, Zhou X, Sun Y, et al. Mitochondria-dependent apoptosis of activated T lymphocytes induced by astin C, a plant cyclopeptide, for preventing murine experimental colitis. Biochem Pharmacol. 2011;82(3):260-8. [
DOI:10.1016/j.bcp.2011.04.013] [
PMID]
39. Mohan S, Abdelwahab SI, Kamalidehghan B, Syam S, May KS, Harmal NS, et al. Involvement of NF-κB and Bcl2/Bax signaling pathways in the apoptosis of MCF7 cells induced by a xanthone compound Pyranocycloartobiloxanthone A. Phytomedicine. 2012;19(11):1007-15. [
DOI:10.1016/j.phymed.2012.05.012] [
PMID]
40. Lindsten T, Zong WX, Thompson CB. Defining the role of the Bcl-2 family of proteins in the nervous system. Neuroscientist. 2005;11(1):10-5. [
DOI:10.1177/1073858404269267] [
PMID]
41. Bivik CA, Larsson PK, Kågedal KM, Rosdahl IK, Ollinger KM. UVA/B-induced apoptosis in human melanocytes involves translocation of cathepsins and Bcl-2 family members. J Invest Dermatol. 2006;126(5):1119-27. [
DOI:10.1038/sj.jid.5700124] [
PMID]
42. Green DR. At the gates of death. Cancer cell. 2006;9(5):328-30. [
DOI:10.1016/j.ccr.2006.05.004] [
PMID]
43. Kato J, Matsushime H, Hiebert SW, Ewen ME, Sherr CJ. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev. 1993;7(3):331-42. [
DOI:10.1101/gad.7.3.331] [
PMID]
44. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell. 1995;81(3):323-30. [
DOI:10.1016/0092-8674(95)90385-2] [
PMID]
45. Paggi MG, Baldi A, Bonetto F, Giordano A. Retinoblastoma protein family in cell cycle and cancer: a review. J Cell Biochem. 1996;62(3):418-30.
https://doi.org/10.1002/(SICI)1097-4644(199609)62:3<418::AID-JCB12>3.0.CO;2-E [
DOI:10.1002/(SICI)1097-4644(199609)62:33.0.CO;2-E]